Quick Takeaways
- Amundi filed SCHEDULE 13G/A for Sanofi Common Stock and American Depositary Receipts (SNY).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2024.
Amundi - 31 Dec 2024 SCHEDULE 13G/A Report for Sanofi Common Stock and American Depositary Receipts (SNY)
- Filing Manager
- Amundi
- Reporting Manager
- AMUNDI
- Symbol
- SNY
- Shares outstanding
- 1,261,458,686 shares
- Disclosed Ownership
- 64,334,393 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 12:14:35 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 12 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Amundi disclosed 5.1% ownership in Sanofi Common Stock and American Depositary Receipts (SNY) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 12:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AMUNDI | 5.1% | 64,334,393 | 0 | 28,690,613 | /s/ Lisa M. Jones | Lisa M. Jones; President and Chief Executive Officer; Head of the Americas Amundi US, Inc.; By Power of Attorney | |
| Amundi Asset Management US, Inc. | 5.1% | 64,334,393 | 0 | 28,690,613 | /s/ Lisa M. Jones | Amundi Asset Management US, Inc. |